IMA ImageneBio, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 5, 2026
$4,60
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$3,94minimo 52 sett.
$9,10massimo 52 sett.
P/E
-0.7
EPS
$-9.64
Ricavi
$800.0K
i tuoi badge
Intervallo 52 sett.
$4–$9
Rating Analisti
STRONG BUY
Prezzo Obiettivo
$18
P/E
-0.7
ROE
192.1%
Margine di Profitto Netto
-5668.6%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
IMA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$4.60
P/E
-0.7
EPS
$-9.64
Ricavi
$800.0K
ROE
192.1%
Intervallo 52 sett.
$4–$9
IMA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 28 Luglio 2025 | 1-for-12 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$800.0K2020-12-31 → 2025-12-31
EPS$-9.642021-12-31 → 2025-12-31
Flusso di cassa libero·2021-12-31 → 2023-12-31
Margine netto-5668.6%2021-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | IMA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -0.7media 5 anni ≈-31.3 | ≈-31.3 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | IMA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Operating Margin (Margine Operativo) | -6056.4%media 5 anni ≈-1861.0% | ≈-1861.0% | -3308.5% | Debole | |
| EBITDA Margin (Margine EBITDA) | -6006.4%media 5 anni ≈-1848.5% | ≈-1848.5% | -1658.2% | Debole | |
| Pretax Margin (Margine ante imposte) | -5712.4% | · | -41.8% | Debole | |
| Net Profit Margin (Margine di Profitto Netto) | -5668.6%media 5 anni ≈-1740.8% | ≈-1740.8% | 8.0% | Debole | |
| ROA | -53.7%media 5 anni ≈-34.0% | ≈-34.0% | -32.6% | Sotto la media | |
| ROE | 192.1%media 5 anni ≈91.1% | ≈91.1% | -15.3% | Di prim'ordine | |
| ROIC | -36.1%media 5 anni ≈-42.5% | ≈-42.5% | -23.4% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | IMA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 21.5media 5 anni ≈10.6 | ≈10.6 | 4.0 | Liquidità elevata | |
| Quick Ratio | 12.0media 5 anni ≈10.4 | ≈10.4 | 3.9 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | IMA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | -77.1%media 5 anni ≈1.4% | ≈1.4% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | -62.9%media 5 anni ≈-38.2% | ≈-38.2% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | -38.6% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | IMA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.1 | ≈0.1 | 0.0 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$44.4K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-8.8%
Prossimo report
Nov 10, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Lug 22, 2026 | $-0.63 | $-0.90 | 30.3% |
| 31 Marzo 2026 | Mag 6, 2026 | $-0.95 | $-0.71 | -33.7% |
| 31 Dicembre 2025 | $-1.42 | $-1.46 | 2.8% | |
| 30 Settembre 2025 | $-2.91 | $-1.29 | -125.1% | |
| 30 Giugno 2025 | $-0.72 | $-1.70 | 57.6% | |
| 31 Marzo 2025 | $-2.16 | $-2.55 | 15.1% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $800.0K | $4M | $9M | $16M | $31M | $9M | |
| R&D Expense | $29M | $32M | $60M | $64M | $47M | $45M | |
| SG&A Expense | $21M | $8M | $25M | $22M | $18M | $9M | |
| Operating Expenses | $49M | $40M | $85M | $87M | $65M | $54M | |
| Operating Income | $-48M | $-37M | $-75M | $-71M | $-34M | $-45M | |
| Interest Income | · | · | $7M | $2M | $23.0K | · | |
| Other Non-op | $717.0K | $71.0K | $-22.0K | $2M | $23.0K | $263.0K | |
| Pretax Income | $-46M | $-37M | $-68M | $-69M | · | · | |
| Income Tax | $-350.0K | $13.0K | $-162.0K | $0 | $0 | · | |
| Net Income | $-45M | $-37M | $-68M | $-69M | $-34M | $-44M | |
| EPS (Basic) | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 | · | |
| EPS (Diluted) | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 | · | |
| Shares (Basic) | 4,870,906 | 1,194,172 | 41,735,081 | 36,188,420 | 27,983,359 | · | |
| Shares (Diluted) | · | 48,258,111 | 41,735,081 | 36,188,420 | 27,983,359 | · | |
| EBITDA | $-48M | $-59M | $-75M | $-71M | $-34M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $95M | $12M | $120M | $60M | $232M | $162M | |
| Short-term Investments | $41M | $0 | $56M | $97M | · | · | |
| Prepaid Expense | $5M | $350.0K | $3M | $3M | $4M | $3M | |
| Other Current Assets | · | · | $1M | $964.0K | $629.0K | $2M | |
| Current Assets | $140M | $12M | $179M | $160M | $237M | $166M | |
| PP&E (Net) | $0 | $8.0K | $2M | $3M | $2M | $1M | |
| PP&E (Gross) | $0 | $341.0K | $5M | $5M | $4M | $2M | |
| Accum. Depreciation | $0 | $333.0K | $3M | $2M | $1M | $688.0K | |
| Other Non-current Assets | $5M | $1M | · | · | · | $872.0K | |
| Total Assets | $153M | $16M | $192M | $172M | $248M | $168M | |
| Accounts Payable | $1M | $5M | $2M | $2M | $2M | $2M | |
| Current Liabilities | $11M | $17M | $14M | $22M | $27M | $28M | |
| Capital Leases | $713.0K | $239.0K | $7M | $4M | $5M | $0 | |
| Other Non-current Liabilities | $870.0K | $0 | $950.0K | · | · | · | |
| Total Liabilities | $20M | $17M | $22M | $25M | $40M | $63M | |
| Common Stock | · | $48.0K | $48.0K | $36.0K | $36.0K | $3.0K | |
| Paid-in Capital | $363M | $2M | $452M | $362M | $353M | $10M | |
| Retained Earnings | $-230M | $-180M | $-282M | $-214M | $-145M | $-111M | |
| AOCI | $87.0K | $-2M | $-48.0K | $-763.0K | · | · | |
| Stockholders' Equity | $133M | $-161M | $-126M | $147M | $208M | $-101M | |
| Liabilities + Equity | $153M | $16M | $192M | $172M | $248M | $168M | |
| Shares Outstanding | · | 48,258,111 | 48,258,111 | 36,257,493 | 35,975,034 | 3,096,903 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $400.0K | $1M | · | · | · | · | |
| Stock-based Comp | $15M | $0 | $8M | $8M | $5M | $2M | |
| Deferred Tax | $0 | $0 | · | · | · | · | |
| Restructuring | · | $4M | · | · | · | · | |
| Other Non-cash | $-18M | · | · | · | · | · | |
| Operating Cash Flow | $-48M | $-21M | $-80M | $-74M | $-60M | $-38M | |
| CapEx | · | · | $414.0K | $1M | $2M | $766.0K | |
| Investing Cash Flow | $-6M | $11M | $64M | $-99M | $-2M | $3M | |
| Debt Issued | $15M | $8M | · | · | · | · | |
| Net Debt Issued | $15M | · | · | · | · | · | |
| Stock Issued | · | · | $37M | · | · | · | |
| Stock Repurchased | · | · | $663.0K | · | · | · | |
| Net Stock Activity | · | · | $-663.0K | · | · | · | |
| Financing Cash Flow | $135M | $7M | $76M | $1M | $132M | $116M | |
| Net Change in Cash | $82M | $-3M | · | · | · | · | |
| Taxes Paid | $23.0K | $221.0K | · | · | · | · | |
| Free Cash Flow | · | · | $-80M | $-76M | $-62M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -6056.4% | · | -823.3% | -454.0% | -110.2% | · | |
| Net Margin | -5668.6% | · | -744.2% | -440.3% | -110.1% | · | |
| Pretax Margin | -5712.4% | · | -745.9% | · | · | · | |
| EBITDA Margin | -6006.4% | · | -823.3% | -454.0% | -110.2% | · | |
| ROA | -53.7% | -29.5% | -37.4% | -32.7% | -16.4% | · | |
| ROE | 192.1% | 367.1% | -41.9% | -45.0% | -16.6% | · | |
| ROIC | -36.1% | -47.0% | -44.3% | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 12.5 | 11.8 | 12.6 | 7.4 | 8.7 | · | |
| Quick Ratio | 12.0 | 11.5 | 12.4 | 7.3 | 8.5 | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.1 | 0.1 | 0.1 | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $2.61 | $3.52 | $4.05 | $5.78 | · | |
| Revenue / Share | · | · | $0.22 | $0.43 | · | · | |
| Cash Flow / Share | · | $-0.95 | $-1.91 | $-2.05 | · | · | |
| Cash / Share | · | $0.82 | $2.48 | $1.65 | $6.45 | · | |
| EPS (TTM) | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -77.1% | -61.8% | -41.3% | -49.6% | 237.0% | · | |
| Revenue CAGR 3Y | -62.9% | -51.7% | -0.12% | · | · | · | |
| Revenue CAGR 5Y | -38.6% | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $800.0K | $4M | $9M | $16M | $31M | · | |
| Net Income TTM | $-45M | $-37M | $-68M | $-69M | $-34M | · | |
| Market Cap | · | $950M | $1.14B | $1.16B | $5.41B | · | |
| P/E | -0.7 | -0.9 | -14.5 | -16.8 | -123.3 | · | |
| P/S | · | 271.3 | 124.5 | 74.1 | 174.7 | · | |
| P/B | · | 7.5 | 6.7 | 7.9 | 26.0 | · | |
| P / Tangible Book | · | · | · | 7.9 | 26.0 | · | |
| P / Cash Flow | · | -20.6 | -14.3 | -15.6 | -89.8 | · | |
| P / FCF | · | · | -14.2 | -15.3 | -87.3 | · | |
| Earnings Yield | -139.7% | -112.3% | -6.9% | -5.9% | -0.81% | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | $800.0K | $0 | $4M | · | · | $658.0K | $1M | $2M | $5M | $5M | $6M | |
| R&D Expense | $7M | $6M | $5M | $16M | $6M | $4M | $9M | $4M | $10M | $10M | $14M | $15M | $15M | $16M | $16M | $19M | |
| SG&A Expense | $5M | $6M | $-370.0K | $11M | $2M | $3M | $-5M | $2M | $5M | $6M | $8M | $6M | $5M | $5M | $5M | $5M | |
| Operating Expenses | $12M | $12M | $3M | $27M | $7M | $7M | $915.0K | $6M | $16M | $18M | $23M | $21M | $20M | $21M | $21M | $24M | |
| Operating Income | $-12M | $-12M | $-2M | $-27M | $-7M | $-6M | $-915.0K | $-2M | $-16M | $-18M | $-22M | $-20M | $-18M | $-16M | $-15M | $-18M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | $2M | $1M | $730.0K | $967.0K | $550.0K | |
| Other Non-op | $374.0K | $341.0K | $-7M | $2M | $9.0K | $-5.0K | $1M | $-1M | $235.0K | $-7.0K | $-580.0K | $-2.0K | $-6.0K | $566.0K | $1M | $538.0K | |
| Pretax Income | $-10M | $-11M | $-10M | $-25M | $-8M | $-6M | $-4M | $-3M | $-14M | $-16M | $-20M | $-17M | $-17M | $-14M | · | · | |
| Income Tax | $16.0K | $10.0K | $-319.0K | $-74.0K | $15.0K | $28.0K | $-76.0K | $0 | $62.0K | $27.0K | · | · | · | · | · | · | |
| Net Income | $-10M | $-11M | $-7M | $-25M | $-8M | $-6M | $-5M | $-3M | $-6M | $-22M | $-19M | $-17M | $-17M | $-14M | $-14M | $-17M | |
| EPS (Basic) | $-0.63 | $-0.95 | $-6.49 | $-2.91 | $-4.46 | $-3.80 | $-18.91 | $-2.58 | $-0.28 | $-0.33 | $-0.40 | $-0.40 | $-0.44 | $-0.39 | $-0.38 | $-0.48 | |
| EPS (Diluted) | $-0.63 | $-0.95 | $-6.49 | $-2.91 | $-4.46 | $-3.80 | $-18.91 | $-2.58 | $-0.28 | $-0.33 | $-0.40 | $-0.40 | $-0.44 | $-0.39 | $-0.38 | $-0.48 | |
| Shares (Basic) | · | 11,211,268 | · | 8,526,781 | 48,258,111 | 1,409,963 | · | 1,400,557 | 48,258,111 | 48,258,111 | · | 43,437,844 | 39,292,710 | 36,257,493 | · | 36,257,074 | |
| Shares (Diluted) | 16,161,721 | 11,211,268 | · | · | 2,406,516 | 2,404,832 | · | 48,258,111 | 48,258,111 | 48,258,111 | · | 43,437,844 | 39,292,710 | 36,257,493 | · | 36,257,074 | |
| EBITDA | $-12M | $-12M | · | $-27M | $-9M | $-11M | · | $-12M | $-16M | $-18M | · | $-20M | $-18M | $-16M | · | $-18M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $95M | $76M | $95M | $103M | $58M | $37M | $12M | $45M | $44M | $53M | $120M | $121M | $71M | $29M | $60M | $67M | |
| Short-term Investments | $41M | $41M | $41M | $39M | $37M | $77M | $0 | $93M | $101M | $104M | $56M | $76M | $86M | $108M | $97M | $107M | |
| Prepaid Expense | $5M | $5M | $5M | $5M | $3M | $3M | $350.0K | $4M | $4M | $4M | $3M | $4M | $3M | $3M | $3M | $4M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $1M | $731.0K | $1M | $964.0K | $1M | |
| Current Assets | $141M | $122M | $140M | $148M | $99M | $117M | $12M | $142M | $149M | $161M | $179M | $201M | $161M | $141M | $160M | $178M | |
| PP&E (Net) | · | · | $0 | $1.0K | $419.0K | $506.0K | $8.0K | $682.0K | $772.0K | $864.0K | $2M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | · | · | $0 | · | · | · | $341.0K | · | · | · | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | · | · | $0 | · | · | · | $333.0K | · | · | · | $3M | $3M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | $5M | $5M | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Total Assets | $152M | $137M | $153M | $161M | $126M | $131M | $16M | $149M | $157M | $173M | $192M | $215M | $172M | $152M | $172M | $190M | |
| Accounts Payable | $977.0K | $568.0K | $1M | $2M | $512.0K | $805.0K | $5M | $2M | $1M | $2M | $2M | $4M | $2M | $3M | $2M | $2M | |
| Current Liabilities | $7M | $7M | $11M | $11M | $7M | $9M | $17M | $9M | $8M | $10M | $14M | $19M | $12M | $14M | $22M | $25M | |
| Capital Leases | $0 | $110.0K | $713.0K | $1M | $2M | $3M | $239.0K | $4M | $5M | $6M | $7M | $8M | $3M | $3M | $4M | $4M | |
| Other Non-current Liabilities | $838.0K | $881.0K | $870.0K | $1M | $1M | $1M | $0 | $1M | $1M | $964.0K | · | · | · | · | · | · | |
| Total Liabilities | $10M | $13M | $20M | $21M | $10M | $13M | $17M | $15M | $15M | $17M | $22M | $28M | $15M | $17M | $25M | $32M | |
| Common Stock | · | · | · | · | $48.0K | $48.0K | · | $48.0K | $48.0K | $48.0K | $48.0K | $44.0K | $42.0K | $36.0K | $36.0K | $36.0K | |
| Paid-in Capital | $393M | $364M | $363M | $363M | $459M | $458M | $2M | $456M | $455M | $454M | $452M | $418M | $403M | $364M | $362M | $360M | |
| Retained Earnings | $-251M | $-241M | $-230M | $-223M | $-343M | $-340M | $-180M | $-322M | $-312M | $-299M | $-282M | $-263M | $-246M | $-228M | $-214M | $-200M | |
| AOCI | $-51.0K | $-17.0K | $87.0K | $94.0K | $65.0K | $99.0K | $-2M | $240.0K | $-350.0K | $-313.0K | $-48.0K | $-290.0K | $-456.0K | $-491.0K | $-763.0K | $-1M | |
| Stockholders' Equity | $142M | $123M | $133M | $140M | $116M | $118M | $-161M | $134M | $143M | $155M | $170M | $155M | $157M | $135M | $147M | $159M | |
| Liabilities + Equity | $152M | $137M | $153M | $161M | $126M | $131M | $16M | $149M | $157M | $173M | $192M | $215M | $172M | $152M | $172M | $190M | |
| Shares Outstanding | · | · | · | · | 48,258,111 | 48,258,111 | · | 48,258,111 | 48,258,111 | 48,258,111 | 48,258,111 | 44,104,672 | 42,299,478 | 36,257,493 | 36,257,493 | 36,257,493 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $0 | $0 | $393.0K | $2.0K | $2.0K | $2.0K | $18.0K | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $911.0K | $876.0K | $51.0K | $14M | $458.0K | $57.0K | $0 | $-3M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | $309.0K | $1M | · | $812.0K | $683.0K | $3M | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-15M | $-7M | $-27M | $-3M | $-7M | $-3M | $13M | $-13M | $-18M | $-22M | $-20M | $-18M | $-20M | $-18M | $-17M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $262.0K | $0 | $0 | $152.0K | $231.0K | $1M | |
| Investing Cash Flow | $-346.0K | $-440.0K | $-1M | $-37M | $25M | $0 | $103.0K | $56M | $4M | $-49M | $20M | $32M | $23M | $-11M | $10M | $36M | |
| Debt Issued | · | · | $0 | $0 | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $-123.0K | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $28M | $-3M | $0 | $122M | $13M | $27.0K | $7M | · | · | · | $60.0K | $39M | · | · | $1.0K | $24.0K | |
| Net Change in Cash | $19M | $-18M | $-9M | $97M | $1M | $-7M | $4M | · | · | · | · | · | · | · | · | · | |
| Taxes Paid | · | · | $9.0K | · | · | · | $220.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-20M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | -1645.8% | -922.6% | -292.0% | · | -279.2% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | -1463.5% | -854.0% | -267.6% | · | -270.8% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | -1645.8% | -922.6% | -292.0% | · | -279.2% | |
| ROA | -7.3% | -7.9% | · | -16.0% | -1.9% | -5.7% | · | -5.6% | -8.3% | -9.9% | · | -8.6% | -8.9% | -7.5% | · | -7.7% | |
| ROE | -7.9% | -8.8% | · | -18.1% | -2.1% | -6.3% | · | -7.1% | -9.2% | -11.1% | · | -11.0% | -10.3% | -8.7% | · | -9.6% | |
| ROIC | -8.3% | -9.8% | · | -19.0% | -7.6% | -9.2% | · | -9.2% | -11.1% | -11.8% | · | · | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.5 | 18.4 | · | 13.2 | 13.5 | 13.3 | · | 15.3 | 18.2 | 15.8 | · | 10.4 | 13.4 | 10.1 | · | 7.1 | |
| Quick Ratio | 20.7 | 17.7 | · | 12.8 | 13.1 | 13.0 | · | 14.9 | 17.7 | 15.5 | · | 10.2 | 13.1 | 9.9 | · | 7.0 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | $2.40 | $2.45 | · | $2.78 | $2.96 | $3.22 | · | $3.52 | $3.70 | $3.72 | · | $4.38 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | $0.03 | $0.05 | $0.15 | · | $0.18 | |
| Cash Flow / Share | · | $-1.32 | · | · | · | $-0.22 | · | · | · | $-0.38 | · | · | · | $-0.55 | · | · | |
| Cash / Share | · | · | · | · | $1.21 | $0.76 | · | $0.94 | $0.92 | $1.10 | · | $2.75 | $1.68 | $0.81 | · | $1.85 | |
| EPS (TTM) | $-10.98 | $-14.81 | · | $-30.08 | $-29.75 | $-25.57 | · | $-3.59 | $-1.41 | $-1.57 | · | $-1.61 | $-1.69 | $-1.82 | · | $-1.28 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $800.0K | $800.0K | · | $800.0K | $4M | · | · | · | $9M | $9M | · | $14M | $19M | $18M | · | $30M | |
| Net Income TTM | $-52M | $-50M | · | $-43M | $-22M | $-20M | · | $-51M | $-65M | $-76M | · | $-63M | $-63M | $-66M | · | $-52M | |
| Market Cap | · | · | · | · | $776M | $741M | · | $1.00B | $956M | $822M | · | $2.29B | $3.33B | $1.50B | · | $1.54B | |
| P/E | -0.5 | -0.3 | · | -0.3 | -0.5 | -0.6 | · | -5.8 | -14.0 | -10.9 | · | -32.3 | -46.6 | -22.7 | · | -33.3 | |
| P/S | · | · | · | · | 180.5 | · | · | · | 104.3 | 89.8 | · | 164.3 | 173.7 | 85.5 | · | 50.8 | |
| P/B | · | · | · | · | 6.7 | 6.3 | · | 7.5 | 6.7 | 5.3 | · | 14.8 | 21.2 | 11.1 | · | 9.7 | |
| P / Tangible Book | · | · | · | · | 6.7 | 6.3 | · | 7.5 | 6.7 | 5.3 | · | 14.8 | 21.2 | 11.1 | · | 9.7 | |
| P / Cash Flow | · | · | · | · | · | -70.2 | · | · | · | -44.9 | · | · | · | -75.9 | · | · | |
| Earnings Yield | -186.1% | -296.2% | · | -369.1% | -185.0% | -166.5% | · | -17.3% | -7.1% | -9.2% | · | -3.1% | -2.1% | -4.4% | · | -3.0% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $800.0K | $4M | $9M | $16M | $31M |
| Margine Operativo % | -6056.4% | · | -823.3% | -454.0% | -110.2% |
| Utile netto | $-45M | $-37M | $-68M | $-69M | $-34M |
| EPS Diluito | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 12.5 | 11.8 | 12.6 | 7.4 | 8.7 |
| Quick Ratio | 12.0 | 11.5 | 12.4 | 7.3 | 8.5 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | · | · | $-80M | $-76M | $-62M |
Proprietari istituzionali (13F) 36 filer · $38.4M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
36
Valore detenuto
$38.4M
Nuove posizioni
4
Posizioni chiuse
8
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 4 (-3 vs trimestre precedente) | 8 (+1 vs trimestre precedente) | 9 (-8 vs trimestre precedente) | 12 (+6 vs trimestre precedente) | +879K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| BVF INC/IL | $6.549.012 | 1.110.002 | 17,04% | Azioni |
| Blue Owl Capital Holdings LP | $5.414.383 | 917.692 | 14,09% | Azioni |
| ORBIMED ADVISORS LLC | $5.364.687 | 909.269 | 13,96% | Azioni |
| Cable Car Capital, LP | $4.611.434 | 781.599 | 12,00% | Azioni |
| Omega Fund Management, LLC | $2.686.630 | 455.361 | 6,99% | Azioni |
| RTW INVESTMENTS, LP | $1.973.226 | 334.445 | 5,13% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.891.056 | 320.518 | 4,92% | Azioni |
| Trails Edge Capital Partners, LP | $1.663.824 | 282.004 | 4,33% | Azioni |
| VANGUARD GROUP INC | $1.642.200 | 238.000 | 4,27% | Azioni |
| BML Capital Management, LLC | $1.184.307 | 200.730 | 3,08% | Azioni |
| Monashee Investment Management LLC | $1.134.830 | 192.344 | 2,95% | Azioni |
| BlackRock, Inc. | $797.030 | 135.090 | 2,07% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $512.887 | 86.930 | 1,33% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $393.329 | 66.666 | 1,02% | Azioni |
| CITADEL ADVISORS LLC | $328.099 | 55.610 | 0,85% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $315.755 | 53.512 | 0,82% | Azioni |
| NEA Management Company, LLC | $295.030 | 50.005 | 0,77% | Azioni |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $295.000 | 50.000 | 0,77% | Azioni |
| HSBC HOLDINGS PLC | $208.449 | 34.228 | 0,54% | Azioni |
| Sofinnova Investments, Inc. | $188.116 | 31.884 | 0,49% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $162.103 | 27.475 | 0,42% | Azioni |
| Rangeley Capital, LLC | $118.531 | 20.090 | 0,31% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $117.410 | 19.900 | 0,31% | Azioni |
| Aldebaran Capital, LLC | $106.932 | 18.124 | 0,28% | Azioni |
| Shay Capital LLC | $106.672 | 18.080 | 0,28% | Azioni |
| MORGAN STANLEY | $98.400 | 16.678 | 0,26% | Azioni |
| GOLDMAN SACHS GROUP INC | $91.362 | 15.485 | 0,24% | Azioni |
| NORTHERN TRUST CORP | $66.499 | 11.271 | 0,17% | Azioni |
| BARCLAYS PLC | $63.702 | 10.797 | 0,17% | Azioni |
| UBS Group AG | $40.586 | 6.879 | 0,11% | Azioni |
| Tower Research Capital LLC (TRC) | $3.983 | 675 | 0,01% | Azioni |
| Vanguard Global Advisers, LLC | $3.552 | 602 | 0,01% | Azioni |
| Caitong International Asset Management Co., Ltd | $2.738 | 464 | 0,01% | Azioni |
| NewEdge Advisors, LLC | $944 | 160 | 0,00% | Azioni |
| JPMORGAN CHASE & CO | $425 | 70 | 0,00% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $142 | 24 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VI LLC, OrbiMed Genesis GP LLC, ORBIMED CAPITAL LLC ×7 depositi | 29 Aprile 2026 | 13,10% | Modifica | · | SEC |
| Omega Fund VI, L.P., Omega Fund VI GP, L.P., Omega Fund VI GP Manager, Ltd., Claudio Nessi, Otello Stampacchia | 21 Aprile 2026 | 8,40% | Deposito iniziale | Investimento passivo | SEC |
| Atlas Venture Fund X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Fund XI, L.P., Atlas Venture Associates XI, L.P., Atlas Venture Associates XI, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC ×2 depositi | 29 Luglio 2025 | 2,10% | Modifica | M&A / vendita | SEC |
| BML Investment Partners, L.P., Leonard Braden Michael ×2 depositi | 28 Luglio 2025 | 1,90% | Modifica | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 23 insider · 12 dirigenti · 13 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kristin Yarema | Chief Executive Officer | 14 Agosto 2026 A | 493.705 | 0 | 0 | $0 |
| Mark Manfredi | President & CEO | 01 Febbraio 2024 A | · | 0 | 0 | $0 |
| Yanina Grant-Huerta | Chief Financial Officer | 14 Agosto 2026 A | 104.000 | 0 | 0 | $0 |
| Jotin Marango | Chief Financial Officer | 25 Luglio 2025 D | 11.146 | 0 | 0 | $0 |
| Robert B Lally | Principal Accounting Officer | 17 Luglio 2026 S | 55.582 | 0 | 2 | $-17.334 |
| Erin Butler | Principal Accounting Officer | 30 Dicembre 2025 A | 25.551 | 0 | 0 | $0 |
| Yufang Lu | Chief Medical Officer | 25 Luglio 2025 A | · | 0 | 0 | $0 |
| Caroline Germa | Chief Medical Officer | 01 Marzo 2024 A | · | 0 | 0 | $0 |
| Jeffrey Ecsedy | Chief Development Officer | 01 Febbraio 2024 A | · | 0 | 0 | $0 |
| Xiaoyan Michelle Zhang | Chief Scientific Officer | 03 Gennaio 2023 A | 44.475 | 0 | 0 | $0 |
| Sergio L. Santillana | Chief Medical Officer | 03 Gennaio 2023 A | · | 0 | 0 | $0 |
| Maude Tessier | Chief Business Officer | 02 Febbraio 2022 A | 100.578 | 0 | 0 | $0 |
| David P Bonita | Direttore | 16 Giugno 2026 A | 287.885 | 0 | 0 | $0 |
| Jonathan Jian Wang | Direttore | 16 Giugno 2026 A | 971.173 | 0 | 0 | $0 |
| Otello Stampacchia | Direttore | 16 Giugno 2026 A | 454.982 | 0 | 0 | $0 |
| Joseph P Slattery | Direttore | 16 Giugno 2026 A | 16.000 | 1 | 0 | $95.840 |
| Stephen Hui Wang | Direttore | 18 Dicembre 2025 A | 12.535 | 0 | 0 | $0 |
| Maria Koehler | Direttore | 07 Giugno 2024 A | · | 0 | 0 | $0 |
| Richard Wooster | Direttore | 07 Giugno 2024 A | · | 0 | 0 | $0 |
| Iain D. Dukes | Direttore | 07 Giugno 2024 A | · | 0 | 0 | $0 |
| Owen Hughes | Direttore | 07 Giugno 2024 A | · | 0 | 0 | $0 |
| FORMELA JEAN FRANCOIS | Direttore | 07 Giugno 2024 A | 1.241.935 | 0 | 0 | $0 |
| Ronald C Renaud JR | Direttore | 09 Giugno 2022 A | · | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 3 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
IMA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 8 analisti
COMPRA
Target mediano
$24.00
+421,7%
3 37,5%
Acquisto forte
3 37,5%
Compra
1 12,5%
Mantieni
0 0,0%
Vendi
1 12,5%
Vendita forte
Target Price a 12 Mesi
3 analisti · 2026-09-30Target medio $18.00 +291,3%
Ora
Prezzo attuale $4.60
Basso$2.00
Media$18.00
Alto$28.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| IMA | · | -0.7 | -77.1% | -5668.6% | 192.1% | · |
| HYPD | $31M | -0.4 | 1318.8% | -5570.6% | -115.6% | 62.7% |
| TLPH | $56M | · | · | -51035.7% | -120.8% | · |
| SCYX | $28M | -3.7 | 450.0% | -41.8% | -18.4% | · |
| BSEM | · | · | · | · | · | · |
| FLNA | · | · | · | · | -112.1% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 5, 2026